日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling

长期使用 Serelaxin 治疗可减轻小鼠缺血性心力衰竭模型中的不良重塑,并调节生物活性鞘脂信号传导

Teja Devarakonda, Juan Valle Raleigh, Adolfo G Mauro, Johana M Lambert, Lauren Ashley Cowart, Fadi N Salloum

Clinical impact of the infrapatellar location in symptomatic peripheral arterial disease patients

髌下位置对有症状外周动脉疾病患者的临床影响

Chiabrando, Juan G; Garagoli, Fernando D; Abraham Foscolo, Maria M; Corna, Giuliana; Fleitas, Maria de Los Milagros; Valle-Raleigh, Juan; Medina de Chazal, Horacio A; Berrocal, Daniel H; Rabellino, Jose M; Bluro, Ignacio M

Measuring frailty in patients with severe aortic stenosis: a comparison of the edmonton frail scale with modified fried frailty assessment in patients undergoing transcatheter aortic valve replacement

评估重度主动脉瓣狭窄患者的虚弱程度:埃德蒙顿虚弱量表与改良Fried虚弱评估在经导管主动脉瓣置换术患者中的比较

Romeo, Francisco J; Smietniansky, Maximiliano; Cal, Mariela; Garmendia, Cristian; Valle Raleigh, Juan M; Seropian, Ignacio M; Falconi, Mariano; Oberti, Pablo; Kotowicz, Vadim; Agatiello, Carla R; Berrocal, Daniel H

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

重组人松弛素-2(Serelaxin)再灌注治疗可通过 eNOS 依赖机制减轻缺血/再灌注损伤后的心肌梗死面积和 NLRP3 炎症小体

Juan Valle Raleigh, Adolfo G Mauro, Teja Devarakonda, Carlo Marchetti, Jun He, Erica Kim, Scott Filippone, Anindita Das, Stefano Toldo, Antonio Abbate, Fadi N Salloum